Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Smoking cessation intervention: 2006 update].

J Cornuz1, J P Zellweger

  • 1PMU, Lausanne.

Revue Medicale Suisse
|August 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical standards for drug-susceptible pulmonary TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

[Smoking cessation: How can we involve patients better in treatment choice?]

Revue des maladies respiratoires·2019
Same author

Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.

Journal of thrombosis and haemostasis : JTH·2017
Same author

[The flexibility of family medicine].

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2016
Same author

Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.

Journal of thrombosis and haemostasis : JTH·2016
Same author

[Transparency in medicine: what are the stakes?].

Revue medicale suisse·2015
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Chemicals in cigarettes increase dependence and consumption. Smoking is linked to type II diabetes and breast cancer, but nicotine replacement therapy is safe for cardiovascular patients, with new drugs showing promise.

Area of Science:

  • Toxicology
  • Public Health
  • Pharmacology

Context:

  • Chemical additives in cigarettes are linked to increased nicotine dependence and smoking rates.
  • Observational studies indicate a significant association between smoking and type II diabetes, even with low consumption (1-4 cigarettes/day).
  • Passive smoking elevates breast cancer risk by 30% in non-smoking women.

Purpose:

  • To review the impact of cigarette additives on dependence and consumption.
  • To summarize the epidemiological evidence linking smoking to type II diabetes and breast cancer.
  • To assess the safety and efficacy of smoking cessation therapies.

Summary:

  • Chemicals in cigarettes may enhance nicotine dependence and consumption.
  • Smoking is associated with increased risks of type II diabetes and breast cancer, with passive smoking posing a significant threat.

Related Experiment Videos

  • Nicotine replacement therapy is safe for individuals with cardiovascular disorders.
  • Emerging pharmacological treatments, including varenicline, rimonabant, topiramate, and nicotine vaccines, show potential for smoking cessation.

    • Impact:

    • Highlights the health risks associated with smoking, including dependence, diabetes, and cancer.
    • Confirms the safety of nicotine replacement therapy for cardiovascular patients.
    • Identifies promising new pharmacological interventions for smoking cessation.